The essential amino acid methionine is most often the first-limiting amino acid of commercially-produced poultry feedstuffs. Supplementary methionine is added either as DL-methionine, as the hydroxy acid, 2-hydroxy 4-methylthiobutanoic acid (Alimet ; HMB) or as the calcium salt of the hydroxy acid, methionine hydroxy analogue (MHA).
It is a number of years since MHA was shown to serve as a source of methionine for poultry (Bird, 1952; Gordon & Sizer, 1955) . Numerous studies since then have attempted to determine the efficiency with which HMB (in the form of the free acid or the analogue) can replace L-and DL-methionine in the diet. In these studies, the effects on growth or egg production of giving supplements of methionine (L or DL) or HMB to birds given basal methionine-deficient diets were usually measured. Of the studies where practical (compound) feedstuffs were used, some show no difference between HMB and L-or DL-methionine (e.g. Gordon & Sizer, 1955; Reid et al. 1982) while others show HMB to be less effective than L-or DL-methionine for supporting growth or egg production (e.g. Smith, 1966; Tipton et al. 1966) . Unfortunately the basal, 'low-methionine' diets used in these studies differ both in composition and degree of methionine deficiency. Studies in which crystalline amino acids (purified diets) are the only source of nitrogen, consistently show that HMB cannot totally replace DL-methionine in the diet (Featherston & Horn, 1974; Katz & Baker, 19750; Christensen et al. 1980; Boebel & Baker, 1982; van Weerden et al. 1982) .
There have been relatively few studies carried out to examine the metabolism of HMB in the chick. D-and L-HMB and D-methionine are converted to L-methionine in the tissues of many animals. Liver and kidney appear to be the major organs performing these transformations both in chicks (Gordon & Sizer, 1955) and in rats (Baker, 1952; Langer, 1965) . Dibner & Knight (1984~) have investigated the enzymes which catalyse the oxidation of 622 C. LINDA SAUNDERSON HMB to the corresponding a-keto acid, 2-keto 4-methylthiobutanoic acid (KMB); the necessary first stage in conversion of HMB to L-methionine. The D-and L-isomers of HMB are oxidized by different enzymes and in different cellular and tissue locations. The D-hydroxy acid dehydrogenase is not only active in the mitochondria1 fractions of liver and kidney but also in skeletal muscle, intestinal mucosa, spleen and brain. This suggests that the two isomers of HMB may differ in the efficiency with which they are used by different tissues.
Gordon & Sizer (1965), using DL-HMB and L-methionine labelled with 35S, found that the radioactivity was incorporated equally well into liver protein and was distributed equally in the blood plasma and excreta (after 24 h) from either material. Dibner (1983) , working with isolated chick hepatocytes, found no difference in the rate of incorporation of labelled HMB or methionine into liver protein. Such studies purport to show equivalence of HMB and L-methionine as a precursor for protein synthesis in spite of the fact that results of many feeding trials are contrary to this hypothesis. Larbier & Perrot (1984) have compared the distribution of 14C-labelled L-methionine, DL-methionine and DL-HMB in liver, breast muscle and blood plasma of young chicks for 24 h following intraperitoneal injection. They found that more 14C from DL-methionine and DL-HMB was present in the 'free pools' (i.e. acid-soluble cell extracts) of all three tissues. The proteins of muscle contained less 14C when L-[~J~C]HMB was given than from either L or ~~-[l-l~C]rnethionine. However, in plasma and to a greater extent in liver the proteins were more highly labelled by DL-
The purpose of the work reported here was to investigate the metabolism in vivo of HMB in young broiler chicks and to examine its ability to replace methionine for protein synthesis in growing tissues. The effectiveness of HMB was compared with both L-methionine and DL-methionine. Preliminary reports of this work have appeared elsewhere (Saunderson 1983a, b) .
M A T E R I A L S A N D M E T H O D S
DL-[ l-14C]methionine, L-[ l-14C]methionine and NaH14C03 were obtained from Amersham International plc, Amersham, Bucks. Specific activity of DL-[ 1 -14C]methionine was 401 ,uCi/mg and of ~-[l-l~C]methionine between 338 and 364 ,uCi/mg (depending on the batch). Radiochemical purity of both materials was 913%.
DL-[I-'~C]HMB was provided by Monsanto Co, St Louis, Missouri, USA and the specific activity of the material received was 35.1 ,uCi/mg and the radiochemical purity was 90%. No attempt was made to purify this material further due to lack of facilities. Although HMB polymerizes spontaneously in concentrated solution (Koban & Koberstein, 1984) , it is unlikely that the DL-[I-'~C]HMB supplied contained any form other than the monomer as it was in dilute solution.
Fisofluor 1 and Fisofluor 3 liquid scintillation cocktails and Fisosolve tissue solubilizer were obtained from Fisons Ltd, Loughborough. Ethanolamine, 2-methoxy ethanol and toluene (' Scintran' grade) and Dowex 1 x 8 C1-form ion-exchange resin were obtained from BDH Chemicals Ltd, Poole, Dorset.
L-methionine, DL-methionine and DL-HMB (Ca2+ salt) were obtained from Sigma Chemical Co. Ltd, Poole, Dorset. All other chemicals were of analytical grade.
Animals and husbandry
Broiler chicks were obtained at l-d-old from D. B. Marshall Ltd, Newbridge, Midlothian or from stock produced at the Poultry Research Centre.
All birds were housed in a heated battery brooder from 1 -d-old until used for experiment (14-32 d). Birds were given free access to food (chick starter ration; Bolton & Blair, 1974) and to water at all times.
Metabolism chamber Oxidation and excretion of administered 14C-labelled materials were measured in individual birds using a metabolism chamber. This consisted of a Perspex animal chamber (300 x 300 x 300 mm) with a sealable lid. The cage floor was a wire platform raised over a removable Perspex tray. Air was drawn through the chamber by means of a small electric pump at a flow-rate of 2.5-3 litres/min. Air from the chamber was passed through a tube, containing small glass beads, in an ice bath. This creates a large cold surface which removes most of the exhaled water vapour which would otherwise reduce the efficiency of collecting and counting exhaled 14C0,. The dried air is then passed through a solution of ethanolamine-2-methoxyethanol (I : 2) to trap CO,. Tests using 14C0, (acidified NaH14C0, solution) released into the empty chamber showed that all radioactivity (> 97%) was collected within 1 h and 65580% of this was present in the collecting solution within 30 min. When a bird was placed in the chamber during such a test, 5-8% of the 14C0, was lost from the trapping solution but could be recovered in a second tube of solution. This implies that the values for oxidation of L-methionine, DL-methionine and DL-HMB may be underestimated by 5-8% of the total. However, as all compounds are affected in the same way the conclusions drawn from the work are unchanged.
Birds (400-600 g body-weight) were randomly selected, weighed and injected intraperitoneally with 2.5 ,uCi/kg body-weight of ~-[l-l~C]methionine or DL-[~-~~C]HMB. At a set time after injection (10, 30, 60, 90, 120 min) one bird was chosen and a blood sample taken from a wing vein. The bird was then killed by cervical dislocation and tissue samples rapidly excised and stored at -20 O . Tissue samples were taken from breast (pectoralis major) and leg muscles (gastrocnemius), liver, kidney, heart, brain, skin, pancreas and intestine (ileum and jejunum). Radioactivity in perchloric acid (PCA)-precipitable and soluble tissue fractions and in protein-free plasma was measured as described later.
Oxidation Immediately after injection the bird was placed in the metabolism chamber, the lid sealed and the pump switched on. While in the chamber all birds had free access to food and water. The ethanolamine-2-methoxyethanol solution (1 0 ml) was changed every hour during the experiment. After 6 h, the bird was removed from the chamber, killed by cervical dislocation and tissue samples rapidly removed and frozen. The excreta were collected and counted for radioactivity as described later.
Preparation of radioactive samples for counting. Tissue samples (1 g) were thawed, homogenized in 4 ml ice-cold PCA solution (1.2 M) then centrifuged at 6000 g for 15 min. Portions of the supernatant fraction were counted for radioactivity in Fisofluor 1. Precipitates were washed with water, then solubilized using Fisosolve and counted in Fisofluor 3. Blood samples were centrifuged at 2000 g for 10 min. Plasma was removed and deproteinized with an equal volume of sulphosalicylic acid solution (50 g/l). After removing the precipitated proteins by centrifugation, plasma radioactivity was measured in Fisofluor 1.
Excreta collected in the metabolism chamber were thoroughly mixed with dilute hydrochloric acid to a known volume (50-150 mI). Solid material was removed by centrifugation and a portion of the supernatant fluid was counted for radioactivity. The 
6000-
Period after administration (min) efficiency of counting the excreta extracts was checked by internal standard and was rarely below 90%. 14C0, in ethanolamine-2-methoxyethanol was counted using 2-methoxyethanol-toluene solution containing 2,5-diphenyloxazole as described by Jeffay & Alvarez (1961) .
Liquid scintillation counting of radioactive samples was carried out using an LKB 1216 liquid-scintillation counter. All samples were counted in 5-ml plastic minivials.
Chromatography of ''C-labelled components of excretion. Separation of 14C-labelled metabolites in excreta extracts was carried out using a method adapted from Spydevold (1979) and La Noue et al. (1970) . Chromatography was performed using a Dowex 1 formate column (6 x 500 mm; Dowex 1 x 8,200-400 mesh) equilibrated with water. The sample was applied in 10 ml water. Components were eluted with 40 ml water followed by 60 ml 2 M-ammonium formate, pH 2.7, at a flow-rate of 1 ml/min (using a high pressure pump) and collected in 2-ml fractions.
Statistical analysis
The effects of chick source, age and body-weight on the results was evaluated by analysis of variance.
Student's t test was used initially to compare the effects of administering labelled compounds on W O , production, 14C in excreta and 14C incorporation into tissue proteins. There was evidence of non-normality (as judged by correlation with the order statistic from a normal distribution) in the values for 14C in excreta and in heart, skin and brain tissue proteins. There seemed to be some chance in heart tissue that this reflected contamination by blood, although every effort was made to avoid this, but in general, no explanation for the non-normal distributions could be found.
Use of the non-parametric Mann-Whitney test (Table 4, [1-14C]HMB in brain tissue were now judged to be significant (see Table 4 ). In other cases the use of the non-parametric test only affected the level of significance. In the values for 14C excretion the treatment effects were so large that the non-parametric test and the t test led to the same conclusions.
RESULTS
Distribution of 14C in the blood plasma over 120 min following injection of DL-[I-W]HMB or ~-[l-l~C]methionine is shown in Fig. 1 . Both L-methionine and DL-HMB appeared rapidly in the plasma but the radioactivity from DL-HMB disappeared more slowly than that from L-methionine. The presence of radioactivity in the PCA-soluble fractions of tissues was also examined over 2 h following administration of DL-[I-I~C]HMB or ~-[ l14CJmethionine (Fig. 2) . A large amount of radioactivity was found in the kidney following DL-[ 1 -14C]HMB injection. This did not happen when L-[ 1 -14C]methionine was given. In liver tissue there was no large accumulation of 14C from DL-[~-~~C]HMB, although the radioactivity from HMB was always higher than that from L-[ lJ4C]methionine ( Fig. 2(b) ). radioactivity present in PCA-soluble fractions of breast and heart muscle ( Fig. 2(c) and ( -[l-l~C] methionine into tissue proteins (PCA-precipitable fraction) was examined, differences between tissues and the two precursors were evident (Fig. 3) . In liver and kidney, the amount of 14C in the tissue proteins was the same whether L-[ l-14C]methionine or DL-[ 1 -l4C]HMB was administered, except possibly at the earliest time point (10min). Since DL-HMB must first be converted to L-methionine before incorporation into protein, a small 'lag' period in DL-[ 1 -14C]HMBderived 14C reaching tissue protein would be expected.
The other tissues examined all behaved in a similar way towards ~-[l-l~C]methionine and to DL-[~J~C]HMB. Examples are shown for breast and heart muscles in Fig. 3(c) and (4. unlikely that any of the 14C0, released would be recycled into amino acids. Metabolites of L-, DL-[ 1 -14C]methionine or DL-[ 1 -14C]HMB which have not undergone decarboxylation will either be excreted via the urine or retained in the tissue proteins as methionine and cysteine or in cytoplasmic pools (methionine, cysteine, S-adenosyl methionine, 2-keto 4-methylthiobutyrate, etc.). Thus the partitioning of the tracer materials in the body can be examined and compared. 14C0, produced will represent oxidation, 14C in excreta will represent other losses from the system and incorporation of 14C into protein will represent utilization.
In all experiments, the source of 1-d-old chicks, the age of the bird used (14-32 d) or its body-weight did not affect the results.
The release of 14C0, and the excretion of 14C-labelled material by birds given L-or ~~-[ l -~~C ] m e t h i o n i n e or DL-[~-'~C]HMB are shown in Table 2 . The oxidation of DLmethionine appeared to be higher than either L-methionine or DL-HMB and the statistical analysis confirms this for the comparison of L-[ 1 -14Clmethionine and DL-[ l-14C]methionine (see Table 4 , p. 630).
Excretion of 14C from the three tracers contrasts with oxidation as birds excreted the three It is possible that the impurities (10%) in the DL-[I-'~C]HMB preparation used led to the high value of 14C in the excreta compared with DL-[ I-14C]methionine and L-[ l-14C]methionine (impurities 2%). In an attempt to clarify this, an examination of the 14C-labelled components in excreta extracts was made. Separation of the 14C components by Dowex chromatography is shown in Fig. 4 . Chromatograms of the materials injected are included for comparison. (Samples applied to the column were adjusted to contain the same levels of radioactivity, therefore they represent different amounts of excreta extracts.) Also there was some variation between birds in the relative proportions of each of the components in the excreta from any one compound thus the chromatograms show average peak heights for a number of birds (three to five). Results show four components in excreta extracts that are common to all three compounds. The component at fraction no. 9 has similar chromatographic properties to methionine while a small amount of material that behaves like DL-[ I-14C]HMB appears only in the excreta from birds given this material. Otherwise, the major components appear to be common to excreta from all three materials administered. The similarity in the pattern and amounts of excreta 14C-labelled compounds show that impurities alone did not account for the additional 10% of administered 14C excreted by birds given DL-[ 1-14C]HMB. The results of both the oxidation and excretion studies suggest that birds metabolize L-methionine, D-methionine and DL-HMB differently.
C . L I N D A S A U N D E R S O N
Incorporation of 14C from L-and DL-[ 1 -14C]methionine and DL-[ I-14C]HMB into proteins of a number of tissues 6 h after administration is shown in Table 3 . 14C incorporation differs with the precursor used and the different tissues responded in different ways towards each. The 14C incorporation into liver proteins was equivalent from each of the three precursors, but in kidney there was a higher incorporation from ~~-[ I -~~C ] m e t h i o n i n e than from either of the other two precursors. This supports earlier conclusions from Fig. 3 (a) and (b) that the precursor pool (methionine and cysteine) for protein synthesis in liver and kidney is equally labelled with 14C irrespective of the tracer given, except for DL-[ 1 -14C]methionine which in kidney appears to produce a higher 14C labelling in the protein precursor pool.
The differences between incorporation of 14C from DL-[ I-14C]HMB into protein of the tissues examined were not large. Although 14C incorporation from DL-[ I -14C]HMB was generally lower, none of the differences were statistically significant (except for the special case in kidney as described previously; see Table 4 ). * P < 0.05, ** P < 0.01, *** P < 0.001.
DISCUSSION
There is much controversy over the efficiency of HMB or MHA as a supplementary source of dietary methionine for chicks and laying hens receiving practical poultry feedstuffs. However, there seems to be little dispute that HMB is not as effective as DL-methionhe in supporting growth in chicks given chemically-defined diets (e.g. Boebel & Baker, 1982; van Weerden ei al. 1982) . A number of reasons have been suggested which may explain the discrepancy. Some authors (Katz & Baker, 1975a; Boebel & Baker, 1982; van Weerden et al. 1982 van Weerden et al. ,1983 suggest that the methionine : cysteine value and the degree of total sulphur amino acid deficiency of the basal diet used can confuse the comparison between DL-HMB and DL-methionine in experiments with practical feedstuffs. A number of workers (Tipton et al. 1966; Lerner et al. 1969; Baker, 1976) have speculated that DL-HMB is not as well absorbed from the intestinal tract as D-and L-methionine. Dibner & Knight (1984b) have shown that L-methionine and DL-HMB are absorbed through the chick intestinal mucosa by different mechanisms. However, both compounds are absorbed rapidly at physiological concentrations in vivo and Dibner & Knight (1 984b) conclude that absorption would be unlikely to limit performance of birds given HMB in the feed. Preliminary work in this laboratory (Saunderson, 1983b) and the results of Saroka & Combs (1983) agree with this conclusion.
Commercial preparations of DL-HMB (in the liquid-free acid-form) contain dimers, trimers and higher polymers of the hydroxy acid. This has led to the suggestion that the presence of the polymers (which may not be completely hydrolysed in vivo) (see Koban & Koberstein, 1984) reduces the availability of DL-HMB to the bird for conversion to L-methionine (Boebel & Baker, 1982; van Weerden et al. 1983) .
The results presented here suggest another possible reason why DL-MHA and DLmethionine (D-methionine) differ in efficiency as a replacement for dietary L-methionine. Birds metabolize DL-HMB differently from L-methionine and probably from D-methionine and consequently DL-HMB, DL-methionine and L-methionine are excreted and incorporated into tissue proteins in different proportions. Although many reports suggest that D-methionine and L-methionine are nutritionally equivalent in chicks (e.g. Tipton et al. 1966) , a report by Katz & Baker (19756) showed that, at low levels of supplementation, L-methionine was superior to D-methionhe.
There may also be differences in metabolism and nutritional efficiency of the D-and L-isomers of HMB. Baker & Boebel (1980) found that D-HMB was more potent in supporting growth than the L-isomer using both soya-bean-protein-based and crystalline amino acid diets. Dibner & Knight (1984b) have shown that the enzymes which oxidize the D-and L-forms of HMB to the a-keto acid are quite distinct in their cellular location, cofactor requirements and tissue distribution. That the D-hydroxy acid dehydrogenase enzyme is more widely distributed in the body tissues suggests that, as Katz & Baker (19756) found, the D-isomer would be more effective as a methionine substitute. This finding may also explain why there is so little difference between the utilization of DL-methionine and DL-HMB in tissues other than liver and kidney. In both cases one of the isomers can be either used unchanged or converted in situ to L-methionine.
Differences in the extent of excretion of the three materials have not been previously reported. The amount of DL-HMB and DL-methionine (D-methionhe) excreted represents a loss of potential L-methionine from the system. The lower incorporation of 14C into proteins in tissues other than liver and kidney reflects this loss. Whether the excretion of significant amounts of DL-[ 1 -W]HMB and D-[ l-14C]methionine is due to inefficiency of the bird in using those materials or whether the excretion pattern leads to less material for protein incorporation cannot be judged from these results alone. The results differ from those reported by Gordon & Sizer (1965), although in their study the tracer used, strain of bird and time of collection were all different from the present work.
Little is known of the excretion of hydroxy acids by chicks, although Gordon & Sizer (1965) discuss work which suggests that the hydroxy acid (but not the keto acid) analogue of methionine can be actively re-absorbed in the kidney. Excretion of D-methionine by chicks is not well documented, but studies with humans and monkeys have shown that only D-methionine is excreted when DL-methionine is administered (Kies et al. 1975; Stegink et al. 1980) . Earlier studies on mammals led to the suggestion that this is due to active re-absorption of L-methionine in the proximal tubule of the kidney (Crampton & Smyth, 1953) . Our results suggest another explanation for such differential excretion in chicks. DL-HMB (Fig. 2 (a) ) and DL-methionhe (results not shown) accumulate in the non-protein fraction of chick kidney, while L-methionine does not (Fig. 2(a) ). Such an accumulation of DL-HMB and D-methionine in kidney leads to elevated excretion compared with L-methionine.
The accumulation of DL-HMB and D-methionine in kidney also indicates that there is a link between the need for conversion of these materials to L-methionine and excretion. Studies in a number of laboratories (Baker, 1952; Tubbs & Greville, 1961 ; Gordon & Sizer, 1965; Langer, 1965) as well as the results presented here suggest that kidney is an important site for conversion of D-methionhe, D-and L-HMB to L-methionine. Elevated levels of DL-HMB and D-methionhe in kidney are beneficial for conversion to L-methionine but unfortunately also encourage excretion.
It is most surprising that there is relatively little difference in oxidation of the three precursors and also that the level of catabolism is so low. This is especially surprising since the same intermediate, 2-keto 4-methylthiobutyric acid, is common to both oxidation of L-methionine and conversion of D-methionine and D-and L-HMB to L-methionine. Catabolism of methionine in the rat takes place primarily in liver and kidney (Mitchell & Benevenga, 1978) and this also appears to be the case in the chick (C. L. Saunderson, unpublished results ). Yet the large differences in distribution of the three tracer materials in kidney do not lead to differences in oxidation. Without a further investigation of the enzymes involved it is difficult to say what controls the rate of 2-keto 4-methylthiobutyrate formation from each of the precursors or the partitioning of this metabolite between the various pathways available to it. (Fig. 2(a) ). This implies that the majority of 14C material present derived from DL-[ 1-14C]HMB appearing in the non-protein fraction was not in the form of L-methionine. On the other hand, liver tissue showed only a slightly higher amount of 14C from L-[I-'~C]HMB in the PCA-soluble fraction. This suggests that, in liver, most of the labelled material is present as L-methionine (or cysteine). These results indicate that metabolism of DL-[ 1-l4C]HMB differs in liver and kidney, liver having a higher proportion of DL-HMB converted to L-methionine. The reason for this difference cannot be deduced from these studies and an examination of the metabolic pathways and their activities in these tissues would be required. Larbier & Perrot (1984) also showed that HMB is efficiently converted to L-methionine in liver tissue. In their experiments they found higher levels of 14C in liver proteins from birds given DL-[ 1 -14C]HMB than from either L-or DL-[ 1 -14C]methionine.
Despite the presence of D-hydroxy acid dehydrogenase in tissues other than liver and kidney (see earlier discussion and Dibner & Knight, 1984a), our results show that utilization of DL-HMB takes place principally in the liver and kidney of the chick. Peripheral tissues showed similar amounts of 14C in the acid-soluble cell fraction ( Fig. 2 and Table 1 ) yet lower 14C incorporated into cell proteins. Larbier & Perrot (1984) showed a similar situation for breast muscle tissue over a 24 h period,
The difficulty with the non-normality of the values for 14C incorporation into heart, skin and brain proteins may also be a consequence of the distribution of the oxidase (and transaminase) enzymes which convert DL-methionine and D-and L-HMB to L-methionine. It is possible that chicks have a genetically-produced variability in the levels of these enzymes in these tissues. It is clear, however, that neither D-methionine nor D-and L-HMB are as efficient as L-methionine as protein precursors in heart, skin and brain. This is especially obvious when the non-normality of the values is accounted for statistically (Table 4) .
Since tissues other than liver and kidney represent a far larger proportion of body protein they therefore provide a more important gauge of the effectiveness of DL-methionine or DL-HMB as a replacement for L-methionine in the diet. The results presented here suggest that studies on one tissue alone (especially liver or kidney) cannot give a proper indication of protein incorporation rates in other body tissues. Therefore previous studies which used liver tissue only (Gordon & Sizer, 1965; Dibner, 1983) could not adequately compare the efficiency of L-methionine and DL-MHA as precursors for whole-body protein synthesis. 
